ReviewArchives of microbiology2026
Hijacked epigenomes: how bacterial effectors rewrite host gene expression.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bacterial pathogens express a variety of effector proteins that act on host cells. These effector proteins, as core virulence factors, enable bacterial pathogens to evade immune clearance, suppress host defense responses, and remodel host cellular metabolism, thereby creating a favorable intracellular niche for pathogen survival and proliferation. Recent studies have revealed that a subset of effector proteins directly or indirectly target host chromatin, reprogramming DNA methylation and histone modifications to reshape cellular transcriptional states. In this review, we synthesize recent advances in bacterial effector-driven epigenetic remodeling, including pathogen-encoded chromatin writers and erasers, manipulation of host epigenetic machinery, signaling-mediated chromatin changes, and metabolite-dependent reprogramming. We further discuss how bacterial effectors gain nuclear access, how infection-associated epigenetic alterations span a continuum from transient adaptation to more persistent infection imprint, and how these strategies are distributed across diverse bacterial lineages and evolutionary routes. Collectively, ongoing research in this area not only deepens our understanding of infectious disease pathogenesis but also reveals epigenetic vulnerabilities that may be exploited for the development of host-directed therapeutic interventions.
Indexed as
Identifiers
42029763What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.